Debate Heats Up On Antitrust Issues Surrounding Medicare Accountable Care Organization Program
This article was originally published in The Gray Sheet
The medical device industry wants the Federal Trade Commission and U.S. Department of Justice to stand firm in their plan to screen out anticompetitive accountable care organizations from the Medicare Shared Savings Program.
You may also be interested in...
Health care attorneys and others pressed Federal Trade Commission officials last week to revise proposed oversight plans of accountable care organizations to better promote participation in the ACO program.
CMS issued its long-awaited accountable care organization proposed rule last week, mapping out the agency's plans for offering providers financial incentives to practice more coordinated and cost-effective health care.
Restructuring the health care system to support integrated patient care by multiple providers will require clear federal guidance on antitrust and related matters, experts said at an Oct. 5 workshop in Baltimore